Merck
MRK
#50
Rank
HK$2.331 T
Marketcap
HK$933.26
Share price
-2.58%
Change (1 day)
36.84%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): HK$56.97

According to Merck's latest financial reports the company's current EPS (TTM) is HK$57.16. an increase over its 2024 EPS that were of HK$52.88.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025HK$56.957.71%
2024HK$52.884308.46%
2023HK$1.20-97.32%
2022HK$44.8210.92%
2021HK$40.4184.68%
2020HK$21.88-27.2%
2019HK$30.0663.44%
2018HK$18.39151.11%
2017HK$7.32-54.58%
2016HK$16.1230.21%
2015HK$12.38-61.99%
2014HK$32.57180.51%
2013HK$11.61-31.82%
2012HK$17.036.62%
2011HK$15.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.13 52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.58 0.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.64-81.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.33-48.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.08 215.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.10 96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.16-71.74%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$23.23-59.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.48-48.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$9.70-83.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel